Psilocybin trials show >93–96% correct guess rates for placebo vs treatment, meaning most participants can tell what they received. Only 2 out of 9 studies formally measured blinding, and functional unblinding was noted across multiple designs regardless of placebo type. This inflates perceived benefits through expectancy bias, making it harder to isolate true drug effects.